BIOCRYST PHARMACEUTICALS INC Insider Trading for March 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOCRYST PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOCRYST PHARMACEUTICALS INC for March 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 07 2014 | BCRX | BIOCRYST PHARMACEU ... | LEE KENNETH B JR | Director | Option Exercise | M | 3.80 | 22,917 | 87,085 | 0 | |
| Mar 07 2014 | BCRX | BIOCRYST PHARMACEU ... | LEE KENNETH B JR | Director | Sell | S | 12.69 | 12,665 | 160,719 | 10,252 | 22.9 K to 10.3 K (-55.26 %) |
| Mar 07 2014 | BCRX | BIOCRYST PHARMACEU ... | LEE KENNETH B JR | Director | Buy | M | 3.80 | 22,917 | 87,085 | 22,917 | 0 to 22.9 K |
| Mar 17 2014 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 4.73 | 3,125 | 14,781 | 24,875 | |
| Mar 17 2014 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 11.24 | 3,125 | 35,125 | 126,616 | 129.7 K to 126.6 K (-2.41 %) |
| Mar 17 2014 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 4.73 | 3,125 | 14,781 | 129,741 | 126.6 K to 129.7 K (+2.47 %) |
| Mar 07 2014 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Option Exercise | M | 8.83 | 23,679 | 209,086 | 0 | |
| Mar 07 2014 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Option Exercise | M | 4.30 | 2,929 | 12,595 | 0 | |
| Mar 07 2014 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Option Exercise | M | 8.83 | 2,208 | 19,497 | 0 | |
| Mar 07 2014 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Sell | S | 12.57 | 40,642 | 510,870 | 208,195 | 248.8 K to 208.2 K (-16.33 %) |
| Mar 07 2014 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Buy | M | 8.83 | 23,679 | 209,086 | 248,837 | 225.2 K to 248.8 K (+10.52 %) |
| Mar 07 2014 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Buy | M | 4.30 | 2,929 | 12,595 | 225,158 | 222.2 K to 225.2 K (+1.32 %) |
| Mar 07 2014 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Buy | M | 8.83 | 2,208 | 19,497 | 222,229 | 220 K to 222.2 K (+1.00 %) |
| Mar 07 2014 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Payment of Exercise | F | 11.69 | 1,618 | 18,914 | 220,021 | 221.6 K to 220 K (-0.73 %) |
| Mar 07 2014 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Option Exercise | M | 1.42 | 10,000 | 14,200 | 90,000 | |
| Mar 07 2014 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Option Exercise | M | 4.15 | 2,518 | 10,450 | 27,482 | |
| Mar 07 2014 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Option Exercise | M | 6.68 | 6,156 | 41,122 | 35,844 | |
| Mar 07 2014 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Option Exercise | M | 4.73 | 12,500 | 59,125 | 37,500 | |
| Mar 07 2014 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Sell | S | 12.63 | 40,734 | 514,470 | 71,622 | 112.4 K to 71.6 K (-36.25 %) |
| Mar 07 2014 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Buy | M | 1.42 | 10,000 | 14,200 | 112,356 | 102.4 K to 112.4 K (+9.77 %) |
| Mar 07 2014 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Buy | M | 4.15 | 2,518 | 10,450 | 102,356 | 99.8 K to 102.4 K (+2.52 %) |
| Mar 07 2014 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Buy | M | 6.68 | 6,156 | 41,122 | 99,838 | 93.7 K to 99.8 K (+6.57 %) |
| Mar 07 2014 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Buy | M | 4.73 | 12,500 | 59,125 | 93,682 | 81.2 K to 93.7 K (+15.40 %) |
| Mar 07 2014 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Payment of Exercise | F | 11.69 | 1,090 | 12,742 | 81,182 | 82.3 K to 81.2 K (-1.32 %) |
| Mar 07 2014 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 4.73 | 3,000 | 14,190 | 28,000 | |
| Mar 07 2014 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 12.69 | 3,000 | 38,070 | 126,616 | 129.6 K to 126.6 K (-2.31 %) |
| Mar 07 2014 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 4.73 | 3,000 | 14,190 | 129,616 | 126.6 K to 129.6 K (+2.37 %) |
| Mar 07 2014 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Payment of Exercise | F | 11.69 | 461 | 5,389 | 126,616 | 127.1 K to 126.6 K (-0.36 %) |
| Mar 07 2014 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Payment of Exercise | F | 11.69 | 5,118 | 59,829 | 630,242 | 635.4 K to 630.2 K (-0.81 %) |
| Mar 07 2014 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Payment of Exercise | F | 11.69 | 1,739 | 20,329 | 137,122 | 138.9 K to 137.1 K (-1.25 %) |